A Look at Acalabrutinib Clinical Trials
CLL Monthly MinutesLeukemia
Ongoing clinical trials are poised to expand the role of acalabrutinib in treating chronic lymphocytic leukemia.
What Your Doctor Should Know About Your Quality of Life
CLL Monthly MinutesLeukemia
Chronic lymphocytic leukemia can have a negative effect on patients’ quality of life, but healthcare teams may be able to minimize the impact.
Lowering the Dose May Not Mean Less Effective Treatment
CLL Monthly MinutesLeukemia
Low-dose chemoimmunotherapy may be an effective first-line therapy for certain patients with chronic lymphocytic leukemia and particular biological and genetic features.
Caregiving Strategies for Supporting Patients with CLL
CLL Monthly MinutesLeukemia
By keeping themselves physically and emotionally healthy, caregivers can give their loved ones the best possible support when helping to care for them.
Lessons Learned from My Journey with Chronic Lymphocytic Leukemia
Patient StoriesLeukemia
George Valentine was diagnosed with chronic lymphocytic leukemia in 2002. He shares some of his hard-learned tips on how to deal with a cancer diagnosis and the high costs of treatment.
Treatment of Chronic Lymphocytic Leukemia During the COVID-19 Pandemic
CLL Monthly MinutesLeukemia
The COVID-19 pandemic has resulted in several changes in how patients with chronic lymphocytic leukemia (CLL) are treated.
From Watchful Waiting to Early Treatment of Asymptomatic Chronic Lymphocytic Leukemia
CLL Monthly MinutesLeukemia
Better identification of patients at high risk of disease progression and newer treatments may mean that fewer newly diagnosed patients must “watch and wait.”
Using Telemedicine to Protect Vulnerable Patients and Provide Access to Care During COVID-19
CLL Monthly MinutesLeukemia
The use of telemedicine has shown rapid growth over the course of the pandemic, with some experts suggesting that it is here to stay.
Studying the Effects of a “Can-Do” Attitude on Cancer Outcomes
CLL Monthly MinutesLeukemia
Can a digital coach improve health outcomes in patients with blood cancers? An ongoing clinical trial should provide insights.
Lenalidomide Maintenance Therapy Linked to B-Cell Acute Lymphoblastic Leukemia
CLL Monthly MinutesLeukemia
Three patients with chronic lymphocytic leukemia were found to have progression to B-ALL after treatment with lenalidomide causing early termination of a clinical study.
Page 1 of 11
Results 1 - 10 of 104

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Race or Ethnicity
Profession or Role
Primary Interest